受强制性开放获取政策约束的文章 - Malcolm Brenner了解详情
无法在其他位置公开访问的文章：4 篇
Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-γ
I Knippertz, A Hesse, T Schunder, E Kämpgen, MK Brenner, G Schuler, ...
Journal of Immunotherapy 32 (5), 524-538, 2009
强制性开放获取政策： German Research Foundation
A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete IL-2 in patients with high-risk neuroblastoma
HV Russell, D Strother, Z Mei, D Rill, E Popek, E Biagi, E Yvon, M Brenner, ...
Journal of immunotherapy 31 (9), 812-819, 2008
强制性开放获取政策： US National Institutes of Health
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): Results from arm 1 of …
BL Musher, EK Rowinsky, BG Smaglo, W Abidi, M Othman, K Patel, ...
The Lancet Oncology 25 (4), 488-500, 2024
强制性开放获取政策： Swedish Research Council
Reversal of exhaustion in engineered T cells
M Mamonkin, MK Brenner
Science 372 (6537), 34-35, 2021
强制性开放获取政策： US National Institutes of Health, Australian Research Council, National …
可在其他位置公开访问的文章：154 篇
Inducible apoptosis as a safety switch for adoptive cell therapy
A Di Stasi, SK Tey, G Dotti, Y Fujita, A Kennedy-Nasser, C Martinez, ...
New England Journal of Medicine 365 (18), 1673-1683, 2011
强制性开放获取政策： US National Institutes of Health
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
MA Pule, B Savoldo, GD Myers, C Rossig, HV Russell, G Dotti, MH Huls, ...
Nature medicine 14 (11), 1264-1270, 2008
强制性开放获取政策： US National Institutes of Health
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
CU Louis, B Savoldo, G Dotti, M Pule, E Yvon, GD Myers, C Rossig, ...
Blood, The Journal of the American Society of Hematology 118 (23), 6050-6056, 2011
强制性开放获取政策： US National Institutes of Health
CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
B Savoldo, CA Ramos, E Liu, MP Mims, MJ Keating, G Carrum, ...
The Journal of clinical investigation 121 (5), 1822-1826, 2011
强制性开放获取政策： US National Institutes of Health
Human epidermal growth factor receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the immunotherapy of HER2-positive sarcoma
N Ahmed, VS Brawley, M Hegde, C Robertson, A Ghazi, C Gerken, E Liu, ...
Journal of clinical oncology 33 (15), 1688-1696, 2015
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
HE Heslop, KS Slobod, MA Pule, GA Hale, A Rousseau, CA Smith, ...
Blood, The Journal of the American Society of Hematology 115 (5), 925-935, 2010
强制性开放获取政策： US National Institutes of Health
HER2-specific chimeric antigen receptor–modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial
N Ahmed, V Brawley, M Hegde, K Bielamowicz, M Kalra, D Landi, ...
JAMA oncology 3 (8), 1094-1101, 2017
强制性开放获取政策： US National Institutes of Health
Design and development of therapies using chimeric antigen receptor‐expressing T cells
G Dotti, S Gottschalk, B Savoldo, MK Brenner
Immunological reviews 257 (1), 107-126, 2014
强制性开放获取政策： US National Institutes of Health
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
M Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, SA Navai, ...
The Journal of clinical investigation 126 (8), 3036-3052, 2016
强制性开放获取政策： US National Institutes of Health
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
V Hoyos, B Savoldo, C Quintarelli, A Mahendravada, M Zhang, J Vera, ...
Leukemia 24 (6), 1160-1170, 2010
强制性开放获取政策： US National Institutes of Health
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
CRY Cruz, KP Micklethwaite, B Savoldo, CA Ramos, S Lam, S Ku, ...
Blood, The Journal of the American Society of Hematology 122 (17), 2965-2973, 2013
强制性开放获取政策： US National Institutes of Health
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
AM Leen, CM Bollard, AM Mendizabal, EJ Shpall, P Szabolcs, JH Antin, ...
Blood, The Journal of the American Society of Hematology 121 (26), 5113-5123, 2013
强制性开放获取政策： US National Institutes of Health
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
A Di Stasi, B De Angelis, CM Rooney, L Zhang, A Mahendravada, ...
Blood, The Journal of the American Society of Hematology 113 (25), 6392-6402, 2009
强制性开放获取政策： US National Institutes of Health
Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b
JA Craddock, AN Lu, A Bear, M Pule, MK Brenner, CM Rooney, AE Foster
Journal of immunotherapy 33 (8), 780-788, 2010
强制性开放获取政策： US National Institutes of Health
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins
CM Bollard, S Gottschalk, V Torrano, O Diouf, S Ku, Y Hazrat, G Carrum, ...
Journal of Clinical Oncology 32 (8), 798-808, 2014
强制性开放获取政策： US National Institutes of Health
CAR T cells administered in combination with lymphodepletion and PD-1 inhibition to patients with neuroblastoma
A Heczey, CU Louis, B Savoldo, O Dakhova, A Durett, B Grilley, H Liu, ...
Molecular therapy 25 (9), 2214-2224, 2017
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定